Table 1 Clinical parameters of enrolled subjects
From: Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders
| Â | SEX | HCV | MC | NHL |
|---|---|---|---|---|
C1 | M | Neg | Neg | Neg |
C2 | M | Neg | Neg | Neg |
C3 | F | Neg | Neg | Neg |
C4 | F | Neg | Neg | Neg |
C5 | F | Neg | Neg | Neg |
P1 | F | Pos | Neg | Neg |
P2 | M | Pos | Neg | Neg |
P3 | F | Pos | Neg | Neg |
P4 | M | Pos | Neg | Neg |
P5 | F | Pos | Neg | Neg |
P6 | F | Pos | n.d. | Follicular |
P7 | F | Pos | n.d. | Marginal |
P8 | F | Pos | n.d. | Diffuse large B cell |
P9 | F | Pos | Pos | Diffuse large B cell |
P10 | F | Pos | n.d. | Neg |